Isolation of scFv fragments specific for monokine induced by interferon-gamma (MIG) using phage display.
Iterative affinity selection procedures were used to isolate a number of single chain Fv (scFv) antibody fragment clones from naïve Tomlinson I+J phage display libraries that specifically recognize and bind a chemokine, monokine induced by interferon-gamma (MIG/CXCL9). MIG is an important transplant rejection/biology chemokine protein. ELISA-based affinity characterization results indicate that selectants preferentially bind to MIG in the presence of key biopanning component materials and closely related chemokine proteins. These novel antibody fragments may find utility as molecular affinity interface receptors in various electrochemical biosensor platforms to provide specific MIG binding capability with potential applications in transplant rejection monitoring, and other biomedical applications where detection of MIG level is important.
Eteshola
Edward
E
Department of Biomedical Engineering, The Ohio State University, Columbus, OH 43230, USA. Edward.Eteshola@osumc.edu
D000595:Amino Acid Sequence; D001667:Binding, Competitive / Q000276:immunology; D054370:Chemokine CXCL9 / Q000276:immunology*; D018925:Chemokines / Q000276:immunology; D003429:Cross Reactions / Q000276:immunology; D004591:Electrophoresis, Polyacrylamide Gel; D004797:Enzyme-Linked Immunosorbent Assay; D000939:Epitopes / Q000276:immunology; D004926:Escherichia coli / Q000235:genetics / Q000378:metabolism; D006801:Humans; D008969:Molecular Sequence Data; D019151:Peptide Library; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology; D057127:Single-Chain Antibodies / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology* / Q000302:isolation & purification*
C080810:CXCL9 protein, human; D054370:Chemokine CXCL9; D018925:Chemokines; D000939:Epitopes; D019151:Peptide Library; D011994:Recombinant Proteins; D057127:Single-Chain Antibodies
Transplant Proc. 2002 Sep;34(6):2217-8
12270371
Nucleic Acids Res. 1991 Aug 11;19(15):4133-7
1908075
J Immunol. 2001 Sep 15;167(6):3494-504
11544343
Methods Enzymol. 1996;267:83-109
8743311
Folia Microbiol (Praha). 2008;53(6):517-20
19381477
J R Soc Interface. 2008 Jan 6;5(18):123-7
17580287
Clin Biochem. 2002 Sep;35(6):425-45
12413604
J Immunol. 2000 Jun 1;164(11):6027-33
10820287
Transplant Proc. 2003 Mar;35(2):875-7
12644173
EMBO J. 1994 Feb 1;13(3):692-8
7508862
J Exp Med. 1998 Jan 5;187(1):129-34
9419219
Am J Pathol. 2002 Oct;161(4):1307-13
12368204
J Immunol. 2002 Aug 1;169(3):1556-60
12133984
Analyst. 2002 Sep;127(9):1137-51
12375833
Hybrid Hybridomics. 2004 Aug;23(4):205-11
15319067
Biotechnol Prog. 2006 May-Jun;22(3):919-22
16739981
J Exp Med. 1998 Mar 16;187(6):875-83
9500790
J Immunol Methods. 2007 Jan 10;318(1-2):95-101
17126854
Chem Rev. 2001 Oct;101(10):3205-18
11710069
Nat Biotechnol. 2000 Sep;18(9):989-94
10973222
Immunotechnology. 1995 Aug;1(2):87-94
9373337
Methods Mol Biol. 2002;178:147-57
11968483
J Mol Biol. 1991 Dec 5;222(3):581-97
1748994
Infect Immun. 2000 Jul;68(7):3888-93
10858199
N Engl J Med. 1998 Feb 12;338(7):436-45
9459648
EMBO J. 1994 Jul 15;13(14):3245-60
8045255
J Virol Methods. 2006 Jun;134(1-2):164-70
16427706
Curr Opin Chem Biol. 2000 Aug;4(4):420-7
10959770
Chem Immunol. 1999;72:1-6
10550926
Science. 1990 Jul 27;249(4967):386-90
1696028
Biomol Eng. 2005 Dec;22(5-6):201-4
16257264